Last reviewed · How we verify

Angiotensin II receptor antagonists, Calcium channel blocker

Advanced-J · FDA-approved active Small molecule Quality 5/100

Angiotensin II receptor antagonists, Calcium channel blocker is a Small molecule drug developed by Advanced-J. It is currently FDA-approved.

At a glance

Generic nameAngiotensin II receptor antagonists, Calcium channel blocker
SponsorAdvanced-J
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Angiotensin II receptor antagonists, Calcium channel blocker

What is Angiotensin II receptor antagonists, Calcium channel blocker?

Angiotensin II receptor antagonists, Calcium channel blocker is a Small molecule drug developed by Advanced-J.

Who makes Angiotensin II receptor antagonists, Calcium channel blocker?

Angiotensin II receptor antagonists, Calcium channel blocker is developed and marketed by Advanced-J (see full Advanced-J pipeline at /company/advanced-j).

What development phase is Angiotensin II receptor antagonists, Calcium channel blocker in?

Angiotensin II receptor antagonists, Calcium channel blocker is FDA-approved (marketed).

Related